ALVO Investor ALERT: Block & Leviton Investigating Alvotech for Securities Fraud; Investors Should Contact the Firm to Potentially Recover Losses

Core Points - Alvotech (NASDAQ: ALVO) is under investigation by Block & Leviton for potential securities law violations following a significant drop in share price [1][2] - The company's shares fell by 33% after receiving a complete response letter from the FDA regarding its biologics license application for AVT05, which was linked to a failed facility inspection [2] - Investors who have incurred losses from their Alvotech investments are encouraged to contact Block & Leviton for potential recovery options [3][4] Investigation Details - Block & Leviton is examining whether Alvotech made any disclosures that may have violated securities laws and is considering filing an action to recover losses for affected investors [4] - The investigation is open to all investors who purchased Alvotech common stock and experienced a decline in share value, regardless of whether they have sold their shares [3] Whistleblower Information - Individuals with non-public information about Alvotech are encouraged to assist in the investigation or report to the SEC under the whistleblower program, which offers rewards of up to 30% of any successful recovery [6] Firm Background - Block & Leviton is recognized as a leading securities class action firm, having recovered billions for defrauded investors and representing many top institutional investors [7]